Health Care & Life Sciences » Biotechnology | Zealand Pharma A/S

Zealand Pharma A/S

Zealand Pharma A/S
Stock Exchange Copenhagen Stock Exchange
EPS
DKK17.75
Market Cap
DKK4.68 B
Shares Outstanding
31.81 M
Public Float
24.48 M

Profile

Address
Smedeland 36
Glostrup ZE 2600
Denmark
Employees -
Website http://www.zealandpharma.com
Updated 07/08/2019
Zealand Pharma A/S is a biotechnology company that engages in the discovery, design, and development of peptide based medicines. Its products include Soliqua and Lyxumia. The company was founded by Lars Hellerung Christiansen and Bjarne Due Larsen on October 19, 1998 and is headquartered in Glostrup, Denmark.

Financials

View All
Created with Highcharts 5.0.14Zealand Pharma A/SNet Income. Fiscal year is January-December. All values DKK Thousands.183 676183 67664 99064 990113 957113 957153 910153 910272 271272 271581 282581 2822013201420152016201720180100k200k300k400k500k600k700k
Created with Highcharts 5.0.14Zealand Pharma A/SSales/Revenue. Fiscal year is January-December. All values DKK Thousands.6 5746 574153 773153 773187 677187 677234 778234 778139 775139 77537 97737 977201320142015201620172018050k100k150k200k250k

Kirsten Dreyer
Director
Jens Peter Stenvang
Director